Study identifier:D5254C00763
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An open single centre study to assess the concentration of budesonide in breast milk from asthmatic women on maintenance treatment w/Pulmicort ® Turbuhaler ® at the dose levels 200/400 µg bid
asthma
Phase 4
No
Pulmicort (budesonide) Turbuhaler
Female
8
Interventional
N/A
Allocation: Non-randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|